Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

LaSara Medical Group vs TD Tele-Doc Weight Loss

LaSara Medical Group
Graded #456

Lower grade

vs+7.299999999999997
TD Tele-Doc Weight Loss
Graded #288

Higher grade

The verdict

TD Tele-Doc Weight Loss takes it — 61.8/100 to 54.5/100.

TD Tele-Doc Weight Loss grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. TD Tele-Doc Weight Loss is a 100% virtual telehealth practice serving Virginia and Maryland that prescribes FDA-approved brand GLP-1 medications (Wegovy, Zepbound, Ozempic, Mounjaro) and compounded…

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueTD Tele-Doc Weight Loss +12
33
45
Dose & formulationLaSara Medical Group +11
64
53
Clinical oversightTD Tele-Doc Weight Loss +19
69
88
Labs & monitoringTD Tele-Doc Weight Loss +12
53
65
FulfillmentTD Tele-Doc Weight Loss +2
66
68
Contract termsTD Tele-Doc Weight Loss +8
47
55
LaSara Medical Group · left barTD Tele-Doc Weight Loss · right bar

The numbers

MetricLaSara Medical GroupTD Tele-Doc Weight Loss
WeighScore54.5/10061.8/100
GradeCC
Scorecard rank#456#288
Semaglutide$289/mo (compounded)Not disclosed
Tirzepatide$399/mo (bundle, compounded)Not disclosed
CoverageCoverage not published2 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
LaSara Medical Group

Graded #456 · C

Strengths

  • Multi-modality clinic — compounded GLP-1s alongside TRT, peptides, B12, NAD+, sermorelin, and enclomiphene
  • National telehealth plus an in-person option in Southern California — uncommon hybrid model
  • Free initial consultation
  • Active promotional pricing (30% off sitewide at the time of review)
  • GLP-1 pricing now published on product pages: compounded semaglutide from $233/mo, tirzepatide from $325/mo on annual bundles

Where it loses points

  • Legal entity name and state of incorporation not disclosed
  • Compounding pharmacy partner not named
  • LegitScript certification status not confirmed
  • Per-state availability not listed despite the national-telehealth claim
  • Lab work and ongoing monitoring inclusion not clearly disclosed for the multi-modality menu
TD Tele-Doc Weight Loss

Graded #288 · C

Strengths

  • Brand Wegovy/Zepbound AND compounded sema available; prescribing based on medical history and coverage
  • 100% virtual — weekly appointments with board-certified MDs from home; no travel required
  • Remote Patient Monitoring Starter Box: biometric scale + blood pressure cuff sync to care team in real time
  • In-network with most commercial insurance plans; may cover visits and monitoring equipment
  • Physician-led by Dr. Peter Wilbanks MD (30-yr OB/GYN, VCU) and Dr. Michael Perini MD (ABIM board-certified)

Where it loses points

  • No public cash pricing; cost entirely depends on insurance coverage — not viable for uninsured patients
  • Telehealth available only in Virginia and Maryland; no national reach confirmed
  • No Medicare or Medicaid accepted; limited to commercial insurance plans only
  • No LegitScript certification found; compounded availability and specific pricing undisclosed on site
  • Tirzepatide (Zepbound/Mounjaro) availability less prominent in MD pages; semaglutide is primary focus

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard